ActivaScrew Cannulated COM
Bioretec, Ltd. · Decision date Sep 4, 2026
What did the FDA decide?
The FDA recorded a substantially equivalent (SESE) decision on September 4, 2026 for ActivaScrew™ Cannulated COM, submitted by Bioretec, Ltd. of Tampere, Finland, under 510(k) number K261057. The device falls under regulation 888.3040, classification name Screw, Fixation, Bone, product code HWC, with an orthopedic review panel. The application was received March 31, 2026, is a traditional 510(k), and was not reviewed by a third party. SESE denotes clearance to market, not premarket approval.
The available FDA letter excerpt references an indication for fixation of bone and osteochondral fractures and osteotomies, dated August 5, 2026, but the excerpt is truncated and the full indication statement is not captured here. The record does not identify a predicate device, summarize the supporting data, or describe any device-specific design changes. Whether the cleared scope matches the indication text as excerpted cannot be confirmed from these sources, so the exact labeled indication should be read from the complete decision letter.
- Regulatory pathway
- 510(k) premarket notification
- Clinical specialty
- Orthopedic
- Decision date
- Sep 4, 2026
FDA source record · MedtechLedger’s explanation describes the recorded change.
Regulatory record facts
- Identifier
- K261057
- Regulatory pathway
- 510(k) premarket notification
- Applicant
- Bioretec, Ltd.
- Product code
- HWC
- Decision code
- SESE
- Decision date
- Sep 4, 2026
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: Screw, Fixation, Bone.
- Applicant
- Bioretec, Ltd.
- Product code
- HWC
- FDA device class
- 2
FDA decision timeline
K261057 received
Application receipt date recorded by FDA.
K261057 · FDA decision
SESE
Related devices and submissions
Explore the linked device profile
Other records with product code HWC
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
| GM Dos Reis Industria e Comercio Ltda. | 510(k) clearance | Nov 2, 2026 | FDA | |
| Nvision Biomedical Technologies | 510(k) clearance | Oct 14, 2026 | FDA | |
| OsteoCentric Technologies | 510(k) clearance | Oct 2, 2026 | FDA | |
Arthrex Beaming SystemK262975 | ARTHREX, INC. | 510(k) clearance | Sep 25, 2026 | FDA |
| MEDSHAPE, INC. | 510(k) clearance | Sep 23, 2026 | FDA |
A shared product code identifies a classification relationship; it does not establish clinical equivalence.
Regulatory context
A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
Bioretec, Ltd.
- Headquarters
- Not reported
- Brand website
- Not reported
- FDA applicant address
- Tampere
Sources and methodology
- Original FDA record: K261057
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 19, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records

